244 related articles for article (PubMed ID: 15890567)
1. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N
Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567
[TBL] [Abstract][Full Text] [Related]
2. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
[TBL] [Abstract][Full Text] [Related]
4. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
5. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
6. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
8. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
Gerhards MF; van Gulik TM; González González D; Rauws EA; Gouma DJ
World J Surg; 2003 Feb; 27(2):173-9. PubMed ID: 12616432
[TBL] [Abstract][Full Text] [Related]
9. External radiotherapy for decompression of cholangiocellular carcinoma with obstructive jaundice: report of a case.
Nakayama H; Tsuji K; Matsui R; Shiotani S; Atake S; Isaka N; Wada M; Tokuuye K; Ishikawa A; Akine Y
Radiat Med; 2001; 19(6):297-301. PubMed ID: 11837580
[TBL] [Abstract][Full Text] [Related]
10. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501
[TBL] [Abstract][Full Text] [Related]
11. External radiotherapy for biliary decompression of hilar cholangiocarcinoma.
Ohnishi H; Asada M; Shichijo Y; Iijima N; Itobayashi E; Shimura K; Suzuki T; Yoshida S; Mine T
Hepatogastroenterology; 1995 Jul; 42(3):265-8. PubMed ID: 7590576
[TBL] [Abstract][Full Text] [Related]
12. Unresectable hilar cholangiocarcinoma completely reduced by external radiation therapy.
Kaido T; Imamura M
Hepatogastroenterology; 2005; 52(63):725-7. PubMed ID: 15966192
[TBL] [Abstract][Full Text] [Related]
13. [Transcutaneous radiotherapy combined with low dose intraluminal brachytherapy in the treatment of non-operable neoplastic stenoses of the bile ducts].
Tana S; Di Russo A; Cerrotta A; Cozzi G; Lozza L; Severini A; Valvo F; Salvetti M; Gardani G
Radiol Med; 1995; 90(1-2):124-8. PubMed ID: 7569076
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
15. High-dose rate intraluminal brachytherapy: An effective palliation for cholangiocarcinoma causing bile duct obstruction.
Nguyen NA; Timotin E; Hunter R; Sur RK
Surg Oncol; 2018 Dec; 27(4):625-629. PubMed ID: 30449482
[No Abstract] [Full Text] [Related]
16. Endoscopic management of cholangiocarcinoma.
Abu-Hamda EM; Baron TH
Semin Liver Dis; 2004 May; 24(2):165-75. PubMed ID: 15192789
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma in a 24-year-old woman with hepatolithiasis.
Leelawat K; Wannaprasert J
J Med Assoc Thai; 2009 Jul; 92(7):983-6. PubMed ID: 19626820
[TBL] [Abstract][Full Text] [Related]
18. Intraluminal brachytherapy in bile duct carcinomas.
Leung J; Guiney M; Das R
Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
Taggar AS; Mann P; Folkert MR; Aliakbari S; Myrehaug SD; Dawson LA
Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
[TBL] [Abstract][Full Text] [Related]
20. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma: regarding Montemaggi et al., IJROBP 32:437; 1995.
Mohan DS; Nori D
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):773-4. PubMed ID: 7558972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
